Lawrence Feldman

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Colorectal cancer statistics, 2023

Cancer statistics, 2023

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera

Activators and target genes of Rel/NF-κB transcription factors

Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells

Role of Transforming Growth Factor β in Human Disease

Head and neck cancer

STAT3 is constitutively active in some patients with Polycythemia rubra vera

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera

Oral complications of cancer and cancer therapy

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders

The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: Continuing research and implications for clinical practice

TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation

Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity

Breast Cancer Statistics, 2022

The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity

Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).

Estimation of the Number of Individuals Living With Metastatic Cancer in the United States

Polycythemia vera: myths, mechanisms, and management

Updates in Hemoglobinopathies

Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma.

A review on the adsorption of heavy metals by clay minerals, with special focus on the past decade

Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cells

Transforming growth factor β and cancer

Defective expression of the SHP-1 phosphatase in polycythemia vera

Current surgical treatment of squamous cell carcinoma of the head and neck

Ascorbate levels in red blood cells and urine in patients with sickle cell anemia

Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States

Phase II 2‐arm trial of the proteasome inhibitor, PS‐341 (bortezomib) in combination with irinotecan or PS‐341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): A trial of the Eastern Cooperative Oncology Group

Review of current treatment practices for carcinoma of the head and neck

Beta 1 integrin expression on human small cell lung cancer cells.